摘要
目的探讨同期手术切除术在治疗食管癌伴发肺癌中的应用价值。方法 20例食管癌并发肺癌患者行食管癌根治性切除术,同期行肺癌根治术治疗。其中左胸一切口施术7例,右胸一切口施术8例,上腹、右胸两切口施术5例。结果20例患者均完成全部手术过程,术后出现并发症5例,无死亡病例。根据手术入路分组,左胸一切口组和右胸一切口组在手术时间、术中出血量、日平均引流量和术后引流管置管时间均显著低于上腹、右胸两切口组(P<0.05或P<0.01)。患者术后随访,2例失访,1、3、5年生存率分别为67.9%、47.4%、44.4%。结论同期手术切除治疗食管癌伴发肺癌效果较好,其中一切口施术方式值得临床借鉴。
Obj ective To evaluate the allocation of homeochronous operative treatment for synchronous primary cancer of esophagus and lung.Methods 20 patients with synchronous prima-ry cancer of esophagus and lung were performed with curative resections of esophagus and lung syn-chronously.Surgical approaches included one incision through left thorax,one incision through right thorax,two incisions though upper abdomen and right thorax,with 7,8 and 5 cases respectively. Results 20 patients completed surgery and 5 of them reported postoperative complications.Accord-ing to the surgical approach,the operative time,blood loss,mean volume of drainage fluid and in-dwelling time significantly reduced in approaches of one incision through left thorax and one incision through right thorax （P〈0.05 orP〈0.01）.2 patients lost to follow up and 1,3,5 years survival rate were 67.9%,47.4%,44.4%respectively.Conclusion Homeochronous operative treatment is feasible for synchronous primary cancer of esophagus and lung.
出处
《实用临床医药杂志》
CAS
2014年第17期158-160,共3页
Journal of Clinical Medicine in Practice
基金
中国高校医学期刊临床专项资金(11321385)
关键词
食管癌
肺癌
多原发癌
出血量
置管时间
esophageal cancer
lung cancer
multiple primary carcinomas
blood loss
in-dwelling time
